All comparisons

Reproductive Policy

Research Preview

Restrict access to mifepristone

Reverse FDA abortion-pill policies, restore tighter dispensing rules and consider withdrawal of mifepristone approval.

Project 2025 said

Paraphrased summary · exact passage under review

Reverse FDA abortion-pill policies, restore tighter dispensing rules and consider withdrawal of mifepristone approval.

Chapter: 14 · Department of Health and Human Services
Author: Research pending
Department: Not specified
Printed page: 458–459
PDF page: 490–491
Preview published: August 16, 2026

Open Project 2025 — Chapter 14, printed page 458PDF viewer page 490

PDF viewer page calculated from the verified 32-page front-matter offset; exact passage still requires editorial verification.

Compared with

Government did

Government-action research is still underway.

No government action, legal status, or policy-alignment conclusion is being presented as verified on this preview.

Action type: Under review
Current status: Under review
In effect: Under review

What still needs review

Verify and quote the exact Project 2025 passage.
Link and verify the relevant official government action, if any.
Independently verify the current legal and implementation status.
Review policy alignment, litigation, and the path to change.

Show me the receipts

1 public source receipt

Our source standard Report a source or factual issue

Project 2025 text

Mandate for Leadership: The Conservative PromiseThe Heritage Foundation · Project 2025 Text · p. 458–459